Company Overview
- Headquarters
- 3801 S Capitol of Tx Hwy Ste 330, Austin TX
- Website
- aileronrx.com
- Phone
- (737) 802-1979
- Employees
- 13
- Founded in
- 2013
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 32 CompaniesNAICS Code 32541 CompaniesNAICS Code 325 CompaniesNAICS Code 3254 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$2B
Who is Lung Therapeutics
Lung Therapeutics is a privately held pharmaceutical company based in Austin, Texas. The company employs 3 individuals and has generated $2 million in revenue. Lung Therapeutics focuses on developing novel therapeutics for orphan drug indications for lung injury and disease, with an emphasis on fibrosis. The company's lead clinical programs include idiopathic pulmonary fibrosis (IPF) and loculated pleural effusion (LPE). Lung Therapeutics is dedicated to improving outcomes for patients with currently available treatments. The company's proprietary pipeline of therapeutics has the potential to greatly improve the lives of those suffering from these debilitating conditions. For more information about Lung Therapeutics, please visit aileronrx.com.
Company Leadership
Lung Therapeutics Industry Tags
Lung Therapeutics Tech Stack
Companies Similar to Lung Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Lung Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 2M | 48 | Rockville, MD | 2002 | |
| 2M | 70 | San Diego, CA | 2008 | |
| 2M | 10 | 2018 | ||
| 2M | 8 | Las Vegas, NV | 1998 | |
| 2M | 6 | Gainesville, FL | 2005 |